Caromed Incorporated

Caromed Incorporated, doing business as Caromed Group Inc., manufactures specialized post-operative and compression medical garments for the Defense Logistics Agency as a prime contractor under a $2.4 million total-small-business-set-aside indefinite delivery contract awarded in February 2026. The company is a self-certified small disadvantaged business and veteran-owned business structured as a Subchapter S Corporation, headquartered in Allentown, Pennsylvania.

Caromed's federal footprint is narrow but operationally dense. The vendor holds a single prime IDC with DLA Troop Support Medical's Electronic Catalog program — the SPE2DE contract vehicle with a $2.4 million ceiling running through February 2031. Under this vehicle, Caromed has received 796 delivery orders (combined potential value $313 thousand) since the initial award on February 25, 2026, alongside an additional 41 orders under a second IDC vehicle (SPE2DE26DA005) totaling $14 thousand. Representative delivery orders include a $6,961.42 order awarded September 15, 2025, for female abdominoplasty garments; a $4,042.36 order awarded January 30, 2026, for unisex multi-flap waistbinders; a $3,731.70 order awarded September 4, 2025, for unisex multi-flap waistbinders; and a $2,731.75 order awarded July 12, 2025, for the same product. Orders range from under $50 to over $6,900, structured as fixed-price contracts with economic price adjustment provisions, with ultimate completion windows typically seven to ten days from award date.

Customer concentration is absolute: Defense Logistics Agency Troop Support Medical accounts for 840 of 841 awards (100 percent of combined potential value) at $7.5 million, with a single outlier order from the Department of the Army Medical Command worth $250 thousand. All work is performed at Caromed's Allentown facility. The vendor's award trajectory shows steep growth — 70 awards in 2022 to 259 in 2025 — though 2026 data is partial (58 awards as of mid-April). The DLA's pre-solicitation notice for this work was posted in July 2023, preceding formal award by over two years.

Caromed's product portfolio centers on surgical support garments: post-augmentation bras, male and female compression vests, abdominoplasty garments (high-back, stage-2, female adjustable variants), unisex multi-flap waistbinders (9-inch and 12-inch), girdles (above-knee, satin), chin-neck garments, jaw garments with gel packs, face lift garments, arm compression sleeves, and reconstruction bras with pouch. PSC coding shows 811 of awards fall under Laboratory Equipment and Supplies, with 29 under Medical and Surgical Instruments, Equipment, and Supplies. Caromed manufactures rather than distributes — the NAICS data distinguishes the company as a surgical appliance and supplies manufacturer on one award and a medical equipment merchant wholesaler on 840 awards, reflecting DLA's Electronic Catalog program classification of delivery orders against the IDC.

The vendor holds no subcontract relationships and operates only as a prime. Real-world invoiced spend represents roughly 4 percent of combined potential value ($327 thousand obligated of $7.8 million potential), consistent with the young contract timeline and the incremental nature of delivery-order fulfillment against the larger ceiling. Caromed competes entirely under total-small-business set-asides; individual delivery orders carry "No Set-Aside Used" designations but derive from and fall under the parent contract's small-business set-aside protection. The compressed award dates and product mix — nearly all orders complete within days of award — indicate a high-velocity supply-chain role serving DLA's immediate medical logistics needs for military personnel post-operative care.